Total Funding
60
58
Total FundingSeries B raised
Growth Score 60 in past quarter
-4 pts
Heat Score 58 in past quarter
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
112811
Free Flow Medical develops a next-generation medical device to treat patients with emphysema.
- Mark Mathis: Founder and CEOPast Role: PneumRx, Co-founder and Chief Technology Officer
About the Company
Free Flow Medical develops a next-generation medical device to treat patients with emphysema, an advanced form of chronic obstructive disease (COPD) that severely limits the quality of life, presents the patient with ongoing severe breathlessness and eventual mortality.
The company's technology includes a minimally-invasive tool that helps
prevent shortness of breath, enabling doctors to help treat patients suffering from emphysema. It incubates inside the Spin-Off Factory and is the first company to be spun out.